Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1340 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Orthofix signs manufacturing agreement with Novation

Through Breg, Orthofix offers products designed to protect against injuries associated with contact sports. Orthofix claims that its BREG division provides quality medical products and services with exceptional

Mercator Therapeutics, Pepscan ink research pact

As per the terms of the agreement, Pepscan will increase the potency and stability of Mercator’s Homing Peptides and license to Mercator the associated intellectual property rights. Pepscan

FDA authorizes Juventas to initiate CLI Phase II trial

The clinical trial will measure several efficacy endpoints including time to amputation, transcutaneous oximetry (TcPO2), Ankle-Brachial Index (ABI) and ulcer closure. Juventas said that JVS-100 encodes Stromal-cell Derived